NAMS
NASDAQ · Biotechnology
Newamsterdam Pharma Co Nv
$27.96
+0.29 (+1.05%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-20.11%
1Y
+10.47%
YTD
-20.57%
Open$28.05
Previous Close$27.67
Day High$28.23
Day Low$27.51
52W High$42.21
52W Low$21.23
Volume—
Avg Volume1.12M
Market Cap3.23B
P/E Ratio—
EPS$-1.77
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$34.11
Below
SMA 200
$28.53
Below
RSI (14)
66.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
+30.2% upside
Current
$27.96
$27.96
Target
$36.39
$36.39
$23.00
$36.39 avg
$47.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 21.98M | 35.84M | 2.72B |
| Net Income | -199,116,570 | -292,150,167 | 249.35M |
| Profit Margin | -905.7% | -860.5% | 9.2% |
| EBITDA | -220,264,969 | -341,134,203 | 355.91M |
| Free Cash Flow | — | — | 147.67M |
| Rev Growth | -38.7% | -38.7% | +24.9% |
| Debt/Equity | — | — | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |